HearingTracker
Financial report · Business & finance← The news desk

✦ The Dispatch

Sonova beats earnings guidance and forecasts growth for 2026/27

A dispatch from MedWatch — filed

Phonak receiver-in-canal hearing aid with a blue dome tip resting on a black cushioned case against a dark background.
✦ PlatePhonak receiver-in-canal hearing aid with a blue dome tip resting on a black cushioned case against a dark background.

The hearing aid group expects sales growth of 5–8 % in its fiscal year, which runs from April to March.

Continue reading at MedWatch

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable change — this is a financial performance report with no direct implications for clinical practice.

✦ Why It Matters ✦

Sonova's continued growth signals a healthy and expanding global hearing aid market, which may influence competitive pricing, product availability, and investment in hearing care innovation.

✦ Key Points ✦
  1. 01Sonova exceeded its earnings guidance for the most recent fiscal period.
  2. 02The company projects 5–8% sales growth for fiscal year 2026/27 (April–March).
  3. 03Reported by MedWatch, an independent trade publication — not a Sonova press release.
  4. 04Growth outlook suggests sustained consumer demand for hearing devices.
  5. 05No specific product launches, clinical data, or practice-change information included.
✦ Claims & Evidence ✦

Sonova exceeded its earnings guidance for the reported fiscal period.

press releaseunclear

Sonova projects 5–8% sales growth for fiscal year 2026/27.

quotepartially supported
✦ Related stories ✦